Brian Goff - Chief Executive Officer, Director at AGIOS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Issuer Symbol: AGIO on Nasdaq
All Insider Reports: All Insider Reports

Brian Goff - trading volume in the past year for AGIOS PHARMACEUTICALS, INC.

	Shares	%	Avg Price	Total $
Buys
Sells	-66,543	100%	$31.01	-$2,063,222
Net	-66,543	-100%		-$2,063,222

Holdings reported by Brian Goff for AGIOS PHARMACEUTICALS, INC.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common stock	164,548	$4,765,310	$28.96	02 Mar 2026	Direct
Performance share units	0	$3,399,519	$44.39	30 Dec 2025	Direct	Common stock
Restricted stock units	26,000	$1,279,440	$35.54	02 Mar 2026	Direct	Common stock
Stock options (right to buy)	174,000			01 Mar 2026	Direct	Common stock

Transactions reported by Brian Goff for AGIOS PHARMACEUTICALS, INC.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.